Kane, John M.

Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine

Kane, J. (1988) · Archives of General Psychiatry

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 4,156

Objective user engagement with mental health apps: systematic search and panel-based usage analysis

Baumel, A., Muench, F., Edan, S., & Kane, J. M. (2019) · Journal of Medical Internet Research

Digital Mental Health InterventionsMobile Health and mHealth Applications

Cited by 965

Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression

Correll, C. U., Galling, B., Pawar, A., Krivko, A., Bonetto, C., Ruggeri, M., Craig, T. J., Nordentoft, M., Srihari, V. H., Guloksuz, S., et al. (2018) · JAMA Psychiatry

Schizophrenia research and treatmentPsychiatric care and mental health services

Cited by 826

Improving outcomes of first‐episode psychosis: an overview

Fusar‐Poli, P., McGorry, P. D., & Kane, J. M. (2017) · World Psychiatry

Schizophrenia research and treatmentPsychiatric care and mental health services

Cited by 575

Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies

Kane, J. M., Kishimoto, T., & Correll, C. U. (2013) · World Psychiatry

Medication Adherence and ComplianceSchizophrenia research and treatment

Cited by 520

Long-Acting Injectable Versus Oral Antipsychotics in Schizophrenia: A Systematic Review and Meta-Analysis of Mirror-Image Studies

Kishimoto, T., Nitta, M., Borenstein, M., Kane, J. M., & Correll, C. U. (2013) · The Journal of Clinical Psychiatry

Schizophrenia research and treatmentPsychiatric care and mental health services

Cited by 427

Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders: Baseline Results From the RAISE-ETP Study

Correll, C. U., Robinson, D. G., Schooler, N. R., Brunette, M. F., Mueser, K. T., Rosenheck, R. A., Marcy, P., Addington, J., Estroff, S. E., Robinson, J., et al. (2014) · JAMA Psychiatry

Schizophrenia research and treatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 384

The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence

Correll, C. U., Citrome, L., Haddad, P. M., Lauriello, J., Olfson, M., Calloway, S. M., & Kane, J. M. (2016) · The Journal of Clinical Psychiatry

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 372

Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies

Kishimoto, T., Hagi, K., Kurokawa, S., Kane, J. M., & Correll, C. U. (2021) · The Lancet Psychiatry

Schizophrenia research and treatmentPsychiatric care and mental health services

Cited by 369

The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research

Potkin, S. G., Kane, J. M., Correll, C. U., Lindenmayer, J.-P., Agid, O., Marder, S. R., Olfson, M., & Howes, O. D. (2020) · npj Schizophrenia

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 359

Single-dose infusion ketamine and non-ketamine N -methyl- d -aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories

Kishimoto, T., Chawla, J. M., Hagi, K., Zarate, C. A., Kane, J. M., Bauer, M., & Correll, C. U. (2016) · Psychological Medicine

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 359

What is the risk‐benefit ratio of long‐term antipsychotic treatment in people with schizophrenia?

Correll, C. U., Rubio, J. M., & Kane, J. M. (2018) · World Psychiatry

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 324

Attention-deficit/hyperactivity disorder: a preliminary diffusion tensor imaging study

Ashtari, M., Kumra, S., Bhaskar, S. L., Clarke, T., Thaden, E., Cervellione, K. L., Rhinewine, J., Kane, J. M., Adesman, A., Milanaik, R., et al. (2005) · Biological Psychiatry

Attention Deficit Hyperactivity DisorderAdvanced Neuroimaging Techniques and Applications

Cited by 295

Standardized remission criteria in schizophrenia

van Os, J., Burns, T., Cavallaro, R., Leucht, S., Peuskens, J., Helldin, L., Bernardo, M., Arango, C., Fleischhacker, W., Lachaux, B., et al. (2006) · Acta Psychiatrica Scandinavica

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 285

Tardive Dyskinesia: Prevalence, Incidence, and Risk Factors

KANE, J. M., WOERNER, M., & LIEBERMAN, J. (1988) · Journal of Clinical Psychopharmacology

Schizophrenia research and treatmentElectroconvulsive Therapy Studies

Cited by 266

CrossCheck: toward passive sensing and detection of mental health changes in people with schizophrenia

Wang, R., Aung, M. S. H., Abdullah, S., Brian, R., Campbell, A. T., Choudhury, T., Hauser, M., Kane, J., Merrill, M., Scherer, E. A., et al. (2016) · Proceedings of the 2016 ACM International Joint Conference on Pervasive and Ubiquitous Computing

Digital Mental Health InterventionsMental Health Research Topics

Cited by 257

Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis

Carbon, M., Kane, J. M., Leucht, S., & Correll, C. U. (2018) · World Psychiatry

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 214

Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia: Systematic Overview and Quality Appraisal of the Meta-analytic Evidence

Correll, C. U., Rubio, J. M., Inczedy-Farkas, G., Birnbaum, M. L., Kane, J. M., & Leucht, S. (2017) · JAMA Psychiatry

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 214

Lithium Carbonate and Imipramine in the Prophylaxis of Unipolar and Bipolar II Illness: A Prospective, Placebo-Controlled Comparison

Kane, J. M. (1982) · Archives of General Psychiatry

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 212

Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment

Sarpal, D. K., Argyelan, M., Robinson, D. G., Szeszko, P. R., Karlsgodt, K. H., John, M., Weissman, N., Gallego, J. A., Kane, J. M., Lencz, T., et al. (2016) · American Journal of Psychiatry

Functional Brain Connectivity StudiesSchizophrenia research and treatment

Cited by 212

Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia: A Randomized Clinical Trial

Kane, J. M., Schooler, N. R., Marcy, P., Correll, C. U., Achtyes, E. D., Gibbons, R. D., & Robinson, D. G. (2020) · JAMA psychiatry

Schizophrenia research and treatmentPsychiatric care and mental health services

Cited by 208

Enlight: A Comprehensive Quality and Therapeutic Potential Evaluation Tool for Mobile and Web-Based eHealth Interventions

Baumel, A., Faber, K., Mathur, N., Kane, J. M., & Muench, F. (2017) · Journal of Medical Internet Research

Mobile Health and mHealth ApplicationsDigital Mental Health Interventions

Cited by 206

Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies

Kishimoto, T., Hagi, K., Nitta, M., Leucht, S., Olfson, M., Kane, J. M., & Correll, C. U. (2018) · Schizophrenia Bulletin

Schizophrenia research and treatmentPsychiatric care and mental health services

Cited by 186

A Collaborative Approach to Identifying Social Media Markers of Schizophrenia by Employing Machine Learning and Clinical Appraisals

Birnbaum, M. L., Ernala, S. K., Rizvi, A. F., De Choudhury, M., & Kane, J. M. (2017) · Journal of Medical Internet Research

Mental Health via WritingSchizophrenia research and treatment

Cited by 168